Stock comparison

MRKvsRGC

Merck & Co IncvsRegencell Bioscience Holdings Ltd. Real data pulled from the alphactor.ai fundamentals pipeline — valuation, balance-sheet health, momentum, and analyst sentiment side by side.

MRK

Merck & Co Inc

$114.62

+15.57%

Pharmaceuticals$298.8BNYSE

RGC

Regencell Bioscience Holdings Ltd

$28.31

+70.54%

Pharmaceuticals$11.9BNASDAQ

60-day price, rebased to 100

MRK +1.10% · RGC -12.33%

Round-by-round

MRK 2·RGC 1· 3ties

Tie

Valuation upside

-26.90% vs — to DCF fair value

EdgeRGC

Balance-sheet strength

Altman Z 4.02 vs 32636.93

Tie

Fundamental quality

Piotroski 4.00 vs 4.00 (of 9)

Tie

Growth + margins

Rule-of-40 20.30 vs —

EdgeMRK

60-day momentum

+1.10% vs -12.33% price return

EdgeMRK

Market-cap liquidity

$298.8B vs $11.9B

Verdict

Across6categories,MRKtakes the edge with2wins to1 (and 3 ties). Neither score is a buy signal on its own: run the full backtest and credibility tests on alphactor.ai before putting money on it.

Backtest a strategy onMRKorRGC

Point-in-time backtests, 8-layer credibility pipeline, conviction scoring — free to start.